Latest European patent oppositions filed by Kilburn & Strode Llp
Patent Number | Title | Applicant | Opposition Date |
---|---|---|---|
EP3590949 | Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses Thereof | MODERNATX, INC. | 2023-02-17 |
EP3407945 | Method For Measuring Flow Features In An Inhaler, Inhaler And System | NOVARTIS AG | 2023-02-06 |
EP3363485 | Metered Dose Inhaler | PRESSPART GMBH & CO. KG | 2023-01-19 |
EP2791160 | Modified Nucleoside, Nucleotide, And Nucleic Acid Compositions | MODERNATX, INC. | 2022-12-02 |
EP3209783 | Permanent Epigenetic Gene Silencing | FONDAZIONE TELETHON | 2022-08-24 |
EP3401335 | Composition Comprising Antibody That Binds To Domain Ii Of Her2 And Acidic Variants Thereof | GENENTECH, INC. | 2022-03-30 |
EP3147295 | New Avv Capsid Proteins For Nucleic Acid Transfer | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2021-09-09 |
EP3199193 | Method For Measuring Flow Features In An Inhaler, Inhaler And System | NOVARTIS AG | 2021-05-26 |
EP3481838 | Novel Processes For The Production Of Oligonucleotides | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED | 2021-05-19 |
EP2228064 | Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor Agonist | NOVARTIS PHARMA GMBH | 2020-09-11 |
Top clients of Kilburn & Strode Llp filing patent oppositions